• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2020 Dec 3;S1201-9712(20)32520-0.
doi: 10.1016/j.ijid.2020.11.204. Online ahead of print.
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany


Marion Ludwig[SUP] 1 [/SUP], Josephine Jacob[SUP] 2 [/SUP], Frederike Basedow[SUP] 2 [/SUP], Frank Andersohn[SUP] 3 [/SUP], Jochen Walker[SUP] 2 [/SUP]



Affiliations

Abstract

Objectives: Since beginning of the SARS-CoV-2 pandemic, there is a discussion about the severity of COVID-19 in comparison to infections with seasonal Influenza. The objective of this study was to compare clinical and demographic characteristics of German patients hospitalized for infection with either SARS-CoV-2 or Influenza.
Methods: This study used anonymized German healthcare claims data. Patients with a confirmed COVID-19 or Influenza diagnosis, for whom a complete hospital course was available (i.e., the patient was discharged or died in hospital) were included. The data set included detailed information on patient characteristics and hospital treatment. Patients were grouped according to whether they were transferred to intensive care unit (ICU), received mechanical ventilation (MV) or had a severe course of the disease (SD). Charlson-Comorbidity-Index in the eight quarters prior to hospitalization and secondary diagnoses during hospitalization were analysed.
Results: A total of 2343 hospitalized COVID-19 patients and 6762 hospitalized Influenza patients were included. 54% of the patients were male, with men being twice as frequent in the COVID-19 severe groups. For both diseases, patients >49 years accounted for almost three-quarters of hospital cases and hypertension, diabetes mellitus, CKD and COPD were the most common comorbidities. The proportion of cases with ICU, MV and SD was substantially higher for COVID-19 patients (ICU+: 21 vs. 13 %; MV+: 15 vs. 9%; SD+: 28 vs. 16%). Overall in-hospital mortality was more than two-fold higher in COVID-19 vs. Influenza (14 vs. 6%).). Length of ventilation and hospitalization, and the proportion of patients diagnosed with ARDS, SIRS or acute kidney injury were considerably higher in COVID-19 patients.
Conclusions: COVID-19 resulted in higher in-hospital mortality and worse clinical outcomes than Influenza. This was not attributable to demographic characteristics, pre-existing comorbidities or patient triage, since the German healthcare system had not reached its limits in the pandemic. Discussions suggesting that COVID-19 and seasonal Influenza have similar severity cannot be based on clinical evidence.

Keywords: COVID-19; Influenza; mechanical ventilation; risk factors.
 
Back
Top Bottom